Test Price
2,800 AED✅ Home Collection Available
MYH7 Gene Cardiomyopathy (Dilated Type 1S) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Interpretation by DHA-licensed genetics specialists.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test analyses the entire coding region of the MYH7 gene to detect pathogenic variants causing dilated cardiomyopathy type 1S, enabling definitive diagnosis, family risk stratification, and personalised cardiac management. The assay identifies single nucleotide variants, small insertions/deletions, and copy number changes with >99% coverage across all exons and flanking regions.
| Feature | Our MYH7 NGS Test | Closest Alternative (Sanger Sequencing Single‑Exon) |
|---|---|---|
| Precision | Full gene sequencing with copy number variant detection (>99% coverage) | Limited to pre‑selected exons; miss deep intronic mutations |
| Methodology | Illumina NGS platform, clinically validated | Sanger chain‑termination method |
| Turnaround Time | 3–4 Weeks | 6–10 Weeks (stepwise exon testing) |
Physician Insight & Safety Protocols
“A MYH7 variant alone does not make a diagnosis; clinical correlation with echocardiography, family history, and symptom assessment is essential. This test provides powerful data, but only your treating cardiologist and a trained genetic counsellor can interpret it within your full clinical picture. As a DHA‑licensed consultant in medical genetics, I strongly recommend pre‑ and post‑test genetic counselling to ensure informed decision‑making.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Advisory Notice
⚠️ Critical Medication Warning
Do not discontinue prescribed medication (e.g., beta‑blockers, ACE inhibitors) without consulting your doctor. This test does not replace emergency cardiac evaluation.
Safety Exclusion Criteria
🚨 Emergency Red Flags – Seek Immediate Medical Attention
- Sudden severe chest pressure or pain
- Loss of consciousness
- Rapid, irregular heartbeat with dizziness
- Difficulty breathing that worsens when lying flat
Exclusion Criteria (Do Not Proceed with Home Collection)
- Acute chest pain or shortness of breath at rest
- Syncope (fainting) within the past 24 hours
- Unstable vital signs (systolic BP <90 mmHg, heart rate >120 bpm)
- Known active COVID‑19 infection
- Inability to provide informed consent without legal guardian
Patient FAQ & Clinical Guidance
1. What exactly does this MYH7 NGS test detect and how long does it take?
Snippet: This test analyses all coding exons and flanking regions of the MYH7 gene by Next Generation Sequencing, returning a comprehensive result in 3 to 4 weeks.
The assay identifies single nucleotide variants, small insertions/deletions, and copy number changes linked to dilated cardiomyopathy type 1S. The 3–4 week turnaround includes bioinformatic analysis and clinical interpretation by a board‑certified molecular geneticist.
2. Is genetic counselling required before giving a blood sample?
Snippet: A pre‑genetic counselling session is strongly recommended to draw a family pedigree and explain potential outcomes, ensuring informed consent.
Our service includes a mandatory counselling session (via teleconsultation) where a genetic counsellor assesses your family history, discusses possible results (pathogenic, VUS, negative), and documents informed consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
3. Can children undergo this test?
Snippet: Testing of minors is permitted only with parental consent and after consultation with a paediatric cardiologist.
In accordance with UAE regulations, genetic testing for minors requires documented parental consent and a clear clinical benefit assessment by a specialist paediatric cardiologist.
UAE Regulatory & Data Privacy Adherence
Your data is protected
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic results are stored in encrypted, access‑controlled databases, shared only with your consent and healthcare team. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Laboratory Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
Clinical & Logistical Metadata
| Test Name | MYH7 Gene Cardiomyopathy (Dilated Type 1S) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina platform |
| ICD-10-CM Code | I42.0 (Dilated cardiomyopathy) |
| LOINC Code | 81324-7 (MYH7 gene full mutation analysis in blood or tissue by NGS) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians